Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 490

1.

Induction of regional chemokine expression in response to human umbilical cord blood cell infusion in the neonatal mouse ischemia-reperfusion brain injury model.

Baba N, Wang F, Iizuka M, Shen Y, Yamashita T, Takaishi K, Tsuru E, Matsushima S, Miyamura M, Fujieda M, Tsuda M, Sagara Y, Maeda N.

PLoS One. 2019 Sep 4;14(9):e0221111. doi: 10.1371/journal.pone.0221111. eCollection 2019.

2.

Temperature-Controlled Locally Excited and Twisted Intramolecular Charge-Transfer State-Dependent Fluorescence Switching in Triphenylamine-Benzothiazole Derivatives.

Kundu A, Karthikeyan S, Sagara Y, Moon D, Anthony SP.

ACS Omega. 2019 Mar 12;4(3):5147-5154. doi: 10.1021/acsomega.8b03099. eCollection 2019 Mar 31.

3.

Development and evaluation of human T-cell leukemia virus-1 and -2 multiplex quantitative PCR.

Kuramitsu M, Okuma K, Tezuka K, Nakamura H, Sagara Y, Kurane I, Hamaguchi I.

Microbiol Immunol. 2019 Aug 20. doi: 10.1111/1348-0421.12740. [Epub ahead of print]

PMID:
31429972
4.

Diffuse distribution of tumor-infiltrating lymphocytes is a marker for better prognosis and chemotherapeutic effect in triple-negative breast cancer.

Hida AI, Watanabe T, Sagara Y, Kashiwaba M, Sagara Y, Aogi K, Ohi Y, Tanimoto A.

Breast Cancer Res Treat. 2019 Aug 12. doi: 10.1007/s10549-019-05390-x. [Epub ahead of print]

PMID:
31402409
5.

National Patterns of Breast Reconstruction and Nipple-Sparing Mastectomy for Breast Cancer, 2005-2015.

Wong SM, Chun YS, Sagara Y, Golshan M, Erdmann-Sager J.

Ann Surg Oncol. 2019 Oct;26(10):3194-3203. doi: 10.1245/s10434-019-07554-x. Epub 2019 Jul 24.

PMID:
31342383
6.

Taxane-based combinations as adjuvant chemotherapy for node-positive ER-positive breast cancer based on 2004-2009 data from the Breast Cancer Registry of the Japanese Breast Cancer Society.

Hojo T, Masuda N, Iwamoto T, Niikura N, Anan K, Aogi K, Ohnishi T, Yamauchi C, Yoshida M, Kinoshita T, Masuoka H, Sagara Y, Sakatani T, Kojima Y, Tsuda H, Kumamaru H, Miyata H, Nakamura S.

Breast Cancer. 2019 Jul 20. doi: 10.1007/s12282-019-00997-w. [Epub ahead of print]

PMID:
31327134
7.

Mechanoresponsive Behavior of a Polymer-Embedded Red-Light Emitting Rotaxane Mechanophore.

Muramatsu T, Sagara Y, Traeger H, Tamaoki N, Weder C.

ACS Appl Mater Interfaces. 2019 Jul 10;11(27):24571-24576. doi: 10.1021/acsami.9b06302. Epub 2019 Jun 28.

PMID:
31251579
8.

Rotaxane-Based Mechanophores Enable Polymers with Mechanically Switchable White Photoluminescence.

Sagara Y, Karman M, Seki A, Pannipara M, Tamaoki N, Weder C.

ACS Cent Sci. 2019 May 22;5(5):874-881. doi: 10.1021/acscentsci.9b00173. Epub 2019 Apr 24.

9.

Infliximab Therapy and the Central Nervous Demyelination in Patients with Kawasaki Disease.

Sagara Y, Muneuchi J, Shimabukuro W, Joo M, Yoshino M, Nakamura R, Yoneda T, Sugitani Y, Watanabe M, Mizushima A, Takahashi Y.

Pediatr Infect Dis J. 2019 Aug;38(8):e185-e187. doi: 10.1097/INF.0000000000002296.

PMID:
31107420
10.

Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study.

Tamura K, Tsurutani J, Takahashi S, Iwata H, Krop IE, Redfern C, Sagara Y, Doi T, Park H, Murthy RK, Redman RA, Jikoh T, Lee C, Sugihara M, Shahidi J, Yver A, Modi S.

Lancet Oncol. 2019 Jun;20(6):816-826. doi: 10.1016/S1470-2045(19)30097-X. Epub 2019 Apr 29. Erratum in: Lancet Oncol. 2019 May 10;:.

PMID:
31047803
11.

Mechano- and Photoresponsive Behavior of a Bis(cyanostyryl)benzene Fluorophore.

Kaneko R, Sagara Y, Katao S, Tamaoki N, Weder C, Nakano H.

Chemistry. 2019 Apr 26;25(24):6162-6169. doi: 10.1002/chem.201900120. Epub 2019 Apr 4.

PMID:
30860632
12.

Generation of a human induced pluripotent stem cell line, BRCi001-A, derived from a patient with mucopolysaccharidosis type I.

Suga M, Kondo T, Imamura K, Shibukawa R, Okanishi Y, Sagara Y, Tsukita K, Enami T, Furujo M, Saijo K, Nakamura Y, Osawa M, Saito MK, Yamanaka S, Inoue H.

Stem Cell Res. 2019 Apr;36:101406. doi: 10.1016/j.scr.2019.101406. Epub 2019 Feb 12.

13.

Functional Polymers Through Mechanochemistry.

Schrettl S, Balkenende DWR, Calvino C, Karman M, Lavrenova A, Neumann LN, Sagara Y, Verde-Sesto E, di Giannantonio M, Simon YC, Fromm KM, Lattuada M, Weder C.

Chimia (Aarau). 2019 Feb 27;73(1):7-11. doi: 10.2533/chimia.2019.7.

PMID:
30813988
14.

Impact of Subtype on Survival of Young Patients With Stage IV Breast Cancer.

Ogiya R, Sagara Y, Niikura N, Freedman RA.

Clin Breast Cancer. 2019 Jun;19(3):200-207.e1. doi: 10.1016/j.clbc.2019.01.005. Epub 2019 Jan 29.

PMID:
30795886
15.

Current status of Neisseria gonorrhoeae cervicitis in pregnant women in Japan.

Suzuki S, Hoshi SI, Sekizawa A, Sagara Y, Tanaka M, Kinoshita K, Kitamura T.

PLoS One. 2019 Feb 7;14(2):e0211595. doi: 10.1371/journal.pone.0211595. eCollection 2019.

16.

The pocket-creation method facilitates colonic endoscopic submucosal dissection (with video).

Takezawa T, Hayashi Y, Shinozaki S, Sagara Y, Okada M, Kobayashi Y, Sakamoto H, Miura Y, Sunada K, Lefor AK, Yamamoto H.

Gastrointest Endosc. 2019 May;89(5):1045-1053. doi: 10.1016/j.gie.2019.01.022. Epub 2019 Feb 1.

PMID:
30716306
17.

Development of Lobular Panniculitis Long After Completing the Personalized Peptide Vaccine Therapy.

Uchida A, Kawasaki E, Tojikubo M, Tamai H, Sagara Y, Nakano Y, Uji Y, Masuda M, Yamaguchi T, Yutani S.

Am J Case Rep. 2018 Dec 27;19:1530-1535. doi: 10.12659/AJCR.912418.

18.

Discrepancy of glutamic acid decarboxylase 65 autoantibody results between RSR radioimmunoassay and enzyme-linked immunosorbent assay in patients with type 1 diabetes is related to autoantibody affinity.

Kawasaki E, Okada A, Uchida A, Fukuyama T, Sagara Y, Nakano Y, Tamai H, Tojikubo M, Koga N.

J Diabetes Investig. 2019 Jul;10(4):990-996. doi: 10.1111/jdi.12996. Epub 2019 Jan 25.

19.

Mechanoresponsive, Luminescent Polymer Blends Based on an Excimer-Forming Telechelic Macromolecule.

Calvino C, Sagara Y, Buclin V, Haehnel AP, Del Prado A, Aeby C, Simon YC, Schrettl S, Weder C.

Macromol Rapid Commun. 2019 Jan;40(1):e1800705. doi: 10.1002/marc.201800705. Epub 2018 Nov 12.

PMID:
30417478
20.

Linked Color Imaging and Blue Laser Imaging for Upper Gastrointestinal Screening.

Osawa H, Miura Y, Takezawa T, Ino Y, Khurelbaatar T, Sagara Y, Lefor AK, Yamamoto H.

Clin Endosc. 2018 Nov;51(6):513-526. doi: 10.5946/ce.2018.132. Epub 2018 Nov 2.

21.

Unusual fluorescent photoswitching of imidazole derivatives: the role of molecular conformation and twist angle controlled organic solid state fluorescence.

Kundu A, Karthikeyan S, Sagara Y, Moon D, Anthony SP.

Phys Chem Chem Phys. 2018 Nov 7;20(43):27385-27393. doi: 10.1039/c8cp05355c.

PMID:
30357180
22.

Impact of Topoisomerase IIα, PTEN, ABCC1/MRP1, and KI67 on triple-negative breast cancer patients treated with neoadjuvant chemotherapy.

Guestini F, Ono K, Miyashita M, Ishida T, Ohuchi N, Nakagawa S, Hirakawa H, Tamaki K, Ohi Y, Rai Y, Sagara Y, Sasano H, McNamara KM.

Breast Cancer Res Treat. 2019 Jan;173(2):275-288. doi: 10.1007/s10549-018-4985-6. Epub 2018 Oct 10.

PMID:
30306430
23.

Does integrated shimming improve lesion detection in whole-body diffusion-weighted examinations of patients with breast cancer?

Sasaki M, Tozaki M, Maruyama K, Benkert T, Murakami W, Yotsumoto D, Oosako S, Sagara Y.

Jpn J Radiol. 2018 Dec;36(12):736-743. doi: 10.1007/s11604-018-0781-9. Epub 2018 Sep 27.

PMID:
30264217
24.

A genome-wide association study identifies three novel genetic markers for response to tamoxifen: A prospective multicenter study.

Onishi H, Udagawa C, Kubo M, Nakamura S, Akashi-Tanaka S, Kuwayama T, Watanabe C, Takamaru T, Takei H, Ishikawa T, Miyahara K, Matsumoto H, Hasegawa Y, Momozawa Y, Low SK, Kutomi G, Shima H, Satomi F, Okazaki M, Zaha H, Onomura M, Matsukata A, Sagara Y, Baba S, Yamada A, Shimada K, Shimizu D, Tsugawa K, Shimo A, Hartman M, Chan CW, Lee SC, Endo I, Zembutsu H.

PLoS One. 2018 Aug 30;13(8):e0201606. doi: 10.1371/journal.pone.0201606. eCollection 2018.

25.

Development of reference material with assigned value for human T-cell leukemia virus type 1 quantitative PCR in Japan.

Kuramitsu M, Okuma K, Nakashima M, Sato T, Sasaki D, Hasegawa H, Umeki K, Kubota R, Sasada K, Sobata R, Matsumoto C, Kaneko N, Tezuka K, Matsuoka S, Utsunomiya A, Koh KR, Ogata M, Ishitsuka K, Taki M, Nosaka K, Uchimaru K, Iwanaga M, Sagara Y, Yamano Y, Okayama A, Miura K, Satake M, Saito S, Watanabe T, Hamaguchi I.

Microbiol Immunol. 2018 Oct;62(10):673-676. doi: 10.1111/1348-0421.12644.

PMID:
30125970
26.

Anticancer Effects of Green Tea and the Underlying Molecular Mechanisms in Bladder Cancer.

Miyata Y, Matsuo T, Araki K, Nakamura Y, Sagara Y, Ohba K, Sakai H.

Medicines (Basel). 2018 Aug 10;5(3). pii: E87. doi: 10.3390/medicines5030087. Review.

27.

Maspin mRNA expression in sentinel lymph nodes predicts non-SLN metastasis in breast cancer patients with SLN metastasis.

Umekita Y, Ohi Y, Iwaya O, Souda M, Sagara Y, Tamada S, Yotsumoto D, Tanimoto A.

Histopathology. 2018 Dec;73(6):916-922. doi: 10.1111/his.13718. Epub 2018 Sep 25.

PMID:
30035819
28.

Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational Study.

Yamashiro H, Sawaki M, Masuda N, Okumura Y, Takano T, Tokunaga E, Saito T, Sagara Y, Yamazaki K, Kawaguchi Y, Lee T, Ozaki S, Yamagami K, Yamamoto N, Kuroi K, Suwa H, Ohtani S, Ito T, Yasuno S, Morita S, Ohno S, Toi M.

Breast Cancer (Auckl). 2018 Jul 5;12:1178223418786243. doi: 10.1177/1178223418786243. eCollection 2018.

29.

Effectiveness of neo-adjuvant systemic therapy with trastuzumab for basal HER2 type breast cancer: results from retrospective cohort study of Japan Breast Cancer Research Group (JBCRG)-C03.

Sagara Y, Takada M, Ohi Y, Ohtani S, Kurozumi S, Inoue K, Kosaka Y, Hattori M, Yamashita T, Takao S, Sato N, Iwata H, Kurosumi M, Toi M.

Breast Cancer Res Treat. 2018 Oct;171(3):675-683. doi: 10.1007/s10549-018-4873-0. Epub 2018 Jul 3.

PMID:
29971625
30.

High Consumption of Green Tea Suppresses Urinary Tract Recurrence of Urothelial Cancer via Down-regulation of Human Antigen-R Expression in Never Smokers.

Yasuda T, Miyata Y, Nakamura Y, Sagara Y, Matsuo T, Ohba K, Sakai H.

In Vivo. 2018 Jul-Aug;32(4):721-729. doi: 10.21873/invivo.11300.

31.

Fine-scale geographic clustering pattern of human T-cell leukemia virus type 1 infection among blood donors in Kyushu-Okinawa, Japan.

Sagara Y, Iwanaga M, Morita M, Sagara Y, Nakamura H, Hirayama H, Irita K.

J Med Virol. 2018 Oct;90(10):1658-1665. doi: 10.1002/jmv.25239. Epub 2018 Jul 10.

32.

Evaluation of Risk of Injury by Extravasation of Hyperosmolar and Vasopressor Agents in a Rat Model.

Shibata Y, Sagara Y, Yokooji T, Taogoshi T, Tanaka M, Hide M, Matsuo H.

Biol Pharm Bull. 2018;41(6):951-956. doi: 10.1248/bpb.b18-00105.

33.

Pathological significance and prognostic roles of densities of CD57+ cells, CD68+ cells, and mast cells, and their ratios in clear cell renal cell carcinoma.

Nakanishi H, Miyata Y, Mochizuki Y, Yasuda T, Nakamura Y, Araki K, Sagara Y, Matsuo T, Ohba K, Sakai H.

Hum Pathol. 2018 Sep;79:102-108. doi: 10.1016/j.humpath.2018.05.007. Epub 2018 May 19.

34.

Randomized phase II study of anastrozole plus tegafur-uracil as neoadjuvant therapy for ER-positive breast cancer in postmenopausal Japanese women (Neo-ACET BC).

Nakayama T, Sagara Y, Takashima T, Matsunami N, Masuda N, Miyoshi Y, Taguchi T, Aono T, Ito T, Kagimura T, Noguchi S.

Cancer Chemother Pharmacol. 2018 Apr;81(4):755-762. doi: 10.1007/s00280-018-3544-5. Epub 2018 Feb 21.

35.

Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY).

Ohtani S, Nakayama T, Yoshinami T, Watanabe KI, Hara F, Sagara Y, Kawaguchi H, Higaki K, Matsunami N, Hasegawa Y, Takahashi M, Mizutani M, Morimoto T, Sato M, Itoh M, Morita S, Masuda N.

Breast Cancer. 2018 Jul;25(4):438-446. doi: 10.1007/s12282-018-0843-y. Epub 2018 Feb 12.

36.

[A Case of Solitary Lymph Node Recurrence Accompanied by Metachronous Multiple Lesion after Definitive Chemoradiotherapy for Esophageal Cancer].

Kawai K, Fujiwara A, Okamura H, Watanabe K, Sagara Y.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1217-1219. Japanese.

PMID:
29394586
37.

Stimuli-Responsive Dual-Color Photon Upconversion: A Singlet-to-Triplet Absorption Sensitizer in a Soft Luminescent Cyclophane.

Mase K, Sasaki Y, Sagara Y, Tamaoki N, Weder C, Yanai N, Kimizuka N.

Angew Chem Int Ed Engl. 2018 Mar 5;57(11):2806-2810. doi: 10.1002/anie.201712644. Epub 2018 Feb 13.

PMID:
29363244
38.

Rotaxanes as Mechanochromic Fluorescent Force Transducers in Polymers.

Sagara Y, Karman M, Verde-Sesto E, Matsuo K, Kim Y, Tamaoki N, Weder C.

J Am Chem Soc. 2018 Feb 7;140(5):1584-1587. doi: 10.1021/jacs.7b12405. Epub 2018 Jan 24.

39.

Erratum to immediate breast volume replacement using a free dermal fat graft after breast cancer surgery: multi-institutional joint research of short-term outcomes in 262 Japanese patients.

Kijima Y, Koriyama C, Fujii T, Hirokaga K, Ishigure K, Kaneko T, Kayano S, Miyamoto S, Sagara Y, Sakurai T, Sakurai T, Sotome K, Ueo H, Wakita K, Watatani M.

Gland Surg. 2017 Dec;6(6):756-757. doi: 10.21037/gs.2017.12.03.

40.

Simultaneous whole-body and breast 18F-FDG PET/MRI examinations in patients with breast cancer: a comparison of apparent diffusion coefficients and maximum standardized uptake values.

Sasaki M, Tozaki M, Kubota K, Murakami W, Yotsumoto D, Sagara Y, Ohi Y, Oosako S, Sagara Y.

Jpn J Radiol. 2018 Feb;36(2):122-133. doi: 10.1007/s11604-017-0707-y. Epub 2017 Nov 20.

PMID:
29159779
41.

Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trial.

Shiroiwa T, Fukuda T, Shimozuma K, Mouri M, Hagiwara Y, Kawahara T, Ohsumi S, Hozumi Y, Sagara Y, Ohashi Y, Mukai H.

BMC Cancer. 2017 Nov 17;17(1):773. doi: 10.1186/s12885-017-3774-7.

42.

A Mini-Review of Reactive Oxygen Species in Urological Cancer: Correlation with NADPH Oxidases, Angiogenesis, and Apoptosis.

Miyata Y, Matsuo T, Sagara Y, Ohba K, Ohyama K, Sakai H.

Int J Mol Sci. 2017 Oct 22;18(10). pii: E2214. doi: 10.3390/ijms18102214. Review.

43.

Injury due to extravasation of thiopental and propofol: Risks/effects of local cooling/warming in rats.

Shibata Y, Yokooji T, Itamura R, Sagara Y, Taogoshi T, Ogawa K, Tanaka M, Hide M, Kihira K, Matsuo H.

Biochem Biophys Rep. 2016 Sep 19;8:207-211. doi: 10.1016/j.bbrep.2016.09.005. eCollection 2016 Dec.

44.

Paradigm Shift toward Reducing Overtreatment of Ductal Carcinoma In Situ of Breast.

Sagara Y, Julia W, Golshan M, Toi M.

Front Oncol. 2017 Aug 28;7:192. doi: 10.3389/fonc.2017.00192. eCollection 2017. Review.

45.

Effects of cytokines derived from cancer-associated fibroblasts on androgen synthetic enzymes in estrogen receptor-negative breast carcinoma.

Kikuchi K, McNamara KM, Miki Y, Moon JY, Choi MH, Omata F, Sakurai M, Onodera Y, Rai Y, Ohi Y, Sagara Y, Miyashita M, Ishida T, Ohuchi N, Sasano H.

Breast Cancer Res Treat. 2017 Dec;166(3):709-723. doi: 10.1007/s10549-017-4464-5. Epub 2017 Aug 22.

PMID:
28831645
46.

Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004-2013.

Sagara Y, Freedman RA, Wong SM, Aydogan F, Nguyen A, Barry WT, Golshan M.

Breast Cancer Res Treat. 2017 Nov;166(2):583-592. doi: 10.1007/s10549-017-4436-9. Epub 2017 Aug 3.

PMID:
28776282
47.

Proviral Features of Human T Cell Leukemia Virus Type 1 in Carriers with Indeterminate Western Blot Analysis Results.

Kuramitsu M, Sekizuka T, Yamochi T, Firouzi S, Sato T, Umeki K, Sasaki D, Hasegawa H, Kubota R, Sobata R, Matsumoto C, Kaneko N, Momose H, Araki K, Saito M, Nosaka K, Utsunomiya A, Koh KR, Ogata M, Uchimaru K, Iwanaga M, Sagara Y, Yamano Y, Okayama A, Miura K, Satake M, Saito S, Itabashi K, Yamaguchi K, Kuroda M, Watanabe T, Okuma K, Hamaguchi I.

J Clin Microbiol. 2017 Sep;55(9):2838-2849. doi: 10.1128/JCM.00659-17. Epub 2017 Jul 12.

48.

Interactions between inflammatory gene polymorphisms and HTLV-I infection for total death, incidence of cancer, and atherosclerosis-related diseases among the Japanese population.

Kairupan TS, Ibusuki R, Kheradmand M, Sagara Y, Mantjoro EM, Nindita Y, Niimura H, Kuwabara K, Ogawa S, Tsumematsu-Nakahata N, Nerome Y, Owaki T, Matsushita T, Maenohara S, Yamaguchi K, Takezaki T.

J Epidemiol. 2017 Sep;27(9):420-427. doi: 10.1016/j.je.2016.08.017. Epub 2017 May 30.

49.

Feasibility of Intraoperative Breast MRI and the Role of Prone Versus Supine Positioning in Surgical Planning for Breast-Conserving Surgery.

Mallory MA, Sagara Y, Aydogan F, DeSantis S, Jayender J, Caragacianu D, Gombos E, Vosburgh KG, Jolesz FA, Golshan M.

Breast J. 2017 Nov;23(6):713-717. doi: 10.1111/tbj.12796. Epub 2017 Mar 10.

50.

Mechano- and Thermoresponsive Photoluminescent Supramolecular Polymer.

Lavrenova A, Balkenende DW, Sagara Y, Schrettl S, Simon YC, Weder C.

J Am Chem Soc. 2017 Mar 29;139(12):4302-4305. doi: 10.1021/jacs.7b00342. Epub 2017 Mar 21.

PMID:
28293946

Supplemental Content

Loading ...
Support Center